Switching to a salt substitute reduces risk of stroke, CV events and death - PACE-CME

Switching to a salt substitute reduces risk of stroke CV events and death

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Non-steroidal MRA effective in reducing CV events in patients with diabetes and CKD
Non-steroidal MRA effective in reducing CV events in patients with diabetes and CKD
ESC 2021
Non-steroidal MRA effective in reducing CV events in patients with diabetes and CKD
- Prof Bertram Pitt
Ground-breaking HF trial with evidence for SGLT2i at EF>40%
Ground-breaking HF trial with evidence for SGLT2i at EF>40%
ESC 2021
Ground-breaking HF trial with evidence for SGLT2i at EF>40%
- Prof. Frank Ruschitzka, MD
Moving the field of medicine and science is a collective exercise
Moving the field of medicine and science is a collective exercise
ESC 2021
Moving the field of medicine and science is a collective exercise
- Prof. Stephan Achenbach, MD
SGLT2 inhibitor benefits patients with HFpEF by reducing clinically meaningful CV events
SGLT2 inhibitor benefits patients with HFpEF by reducing clinically meaningful CV events
ESC 2021
SGLT2 inhibitor benefits patients with HFpEF by reducing clinically meaningful CV events
- Prof. Stefan Anker, MD, PhD